Millennium Management’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Millennium Management’s Portfolio OPXAW Stock Details OPXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,600,000	Closed	-$27K	–	4140
2017 Q1	$27K	Hold	1,600,000	–	–	﹤0.01%	3420
2016 Q4	$32K	Hold	1,600,000	–	–	﹤0.01%	3269
2016 Q3	$142K	Hold	1,600,000	–	–	﹤0.01%	3064
2016 Q2	$40K	Hold	1,600,000	–	–	﹤0.01%	3085
2016 Q1	$112K	Hold	1,600,000	–	–	﹤0.01%	3066
2015 Q4	$160K	Hold	1,600,000	–	–	﹤0.01%	3164
2015 Q3	$190K	Hold	1,600,000	–	–	﹤0.01%	3132
2015 Q2	$272K	Buy	+1,600,000	New	+$239K	﹤0.01%	2925

Other funds holding OPXAW

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Millennium Management's OPXAW Position: Q2 2017 in Review

Millennium Management sold out of Opexa Therapeutics, Inc. (OPXAW) in Q2 2017, closing a stake of 1,600,000 shares — an estimated $27K sold.

Millennium Management first reported a position in OPXAW in Q2 2015 and held it in 8 quarters. The position peaked at $272K in Q2 2015. 4 funds tracked by Wall St. Rank hold OPXAW as of Q2 2017.

Millennium Management reported no remaining Opexa Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
Millennium Management sold 1,600,000 Opexa Therapeutics, Inc. shares in Q2 2017, an estimated $27K.
Millennium Management first reported a position in Opexa Therapeutics, Inc. in Q2 2015 and held it in 8 quarters.
Millennium Management's Opexa Therapeutics, Inc. position peaked at $272K in Q2 2015.
4 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q2 2017.

Based on Millennium Management's 13F filing for Q2 2017, filed 14 Aug 2017.